Turning Point Therapeutics (NASDAQ: TPTX) Gains Ahead Of The Piper Jaffray 31ST Annual Healthcare...

The IPO craze that was there at the beginning of the year seems to have died out. However, there are a few that continue to...

InMode Ltd (NASDAQ: INMD) Sustains Record Gains Post-IPO

Several high profile IPOs have underperformed this year. However, InMode Ltd (NASDAQ: INMD) is an exception. This stock has been on an upward trajectory since...

Silk Road Medical (NASDAQ: SILK) Continues To Make Positive Progress Months After IPO

It has been a rollercoaster ride for Silk Road Medical Inc since its IPO. The gained significantly after the IPO, hit resistance at $50, and...

Cortexyme Inc (NASDAQ: CRTX) Gains Momentum as It Presents on Alzheimer’s Treatment

Like all other IPOs this year, Cortexyme Inc (NASDAQ: CRTX) has had mixed results post listing. After the initial hype, the stock collapsed, but it...

Tela Bio Inc (NASDAQ: TELA) Sustains Positive Sentiment Post IPO

Tela Bio Inc (NASDAQ: TELA) went public on the 13th of November at an offer price of $13. The stock offer was for 4 million...

Oportun Financial Corporation (NASDAQ: OPRT) Sustains Gains Post-IPO after Strong Q3 Results

Oportun Financial Corporation (NASDAQ: OPRT) has been gaining ever since it went public. The company went public on the 26th of September at an offer...

Could Berubicin Unlock Growth Potential for CNS Pharmaceuticals (CNSP)?

On the 13th of November, CNS Pharmaceuticals Inc closed its IPO of 2.125 million shares at $4. Since then, the company has been oscillating around this...

SiTime Corporation (NASDAQ: SITM) Gains Momentum Weeks after IPO

On the 25th of November SiTime Corporation (NASDAQ: SITM) announced that it had completed its IPO. The initial public offer was for 4,945,000 of the...

Datadog Inc (NASDAQ: DDOG) Maintains Impressive Run Post-IPO

Datadog Inc (NASDAQ: DDOG) has had an impressive run since it went public in September. This follows a series of positive news that underpin the...

Springworks Therapeutics (NASDAQ: SWTX) Boosted by Progress in Initial Phase of 2b ReNeu Clinical...

Springworks Therapeutics Inc (NASDAQ: SWTX) has gained significantly since it went public at an offer price of $18 in September. As of yesterday’s close, the...

Must Read